# Enliven Therapeutics (ELVN) - Q1 2026 earnings

Reported May 7, 2026.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | Not available |
| EPS | $-0.38 | $-0.44 |

Earnings filing reader: [8-K 0001193125-26-211921](https://www.opencapital.sh/filings/0001193125-26-211921)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001193125-26-211921.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1672619/000119312526211921/0001193125-26-211921-index.htm)
Periodic report: 10-Q - https://www.sec.gov/Archives/edgar/data/1672619/000119312526211982/0001193125-26-211982-index.htm
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/elvn/earnings/q1-2026